The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of MRX34, a liposomal miR-34 mimic, on target gene expression in human white blood cells (hWBCs): qRT-PCR results from a first-in-human trial of microRNA cancer therapy.
 
Heidi J. Peltier
No Relationships to Disclose
 
Kevin Kelnar
Employment - Mirna Therapeutics
Stock and Other Ownership Interests - Mirna Therapeutics
Patents, Royalties, Other Intellectual Property - No royalty payments have been received, merely R&D patents have been filed/issued.
Travel, Accommodations, Expenses - Mirna Therapeutics
 
Andreas G. Bader
Employment - Mirna Therapeutics
Stock and Other Ownership Interests - Mirna Therapeutics
Patents, Royalties, Other Intellectual Property - Inventor on patents and patent applications assigned to Mirna Therapeutics